Since the high concentration of extracellular NAD+ is present in the TME niche in some cancer types, probably due in part to the altered metabolism in cancer cells, the non-classical eADO production pathway mediated by CD38 also plays an influential role in eADO signaling in several solid tumors (22, 79). The gene discussed is CD38; the disease is cancer.